Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 87

1.

Fracture risk prediction: importance of age, BMD and spine fracture status.

Krege JH, Wan X, Lentle BC, Berger C, Langsetmo L, Adachi JD, Prior JC, Tenenhouse A, Brown JP, Kreiger N, Olszynski WP, Josse RG, Goltzman D; CaMos Research Group.

Bonekey Rep. 2013 Sep 4;2:404. doi: 10.1038/bonekey.2013.138. eCollection 2013.

2.

Peak bone mass from longitudinal data: implications for the prevalence, pathophysiology, and diagnosis of osteoporosis.

Berger C, Goltzman D, Langsetmo L, Joseph L, Jackson S, Kreiger N, Tenenhouse A, Davison KS, Josse RG, Prior JC, Hanley DA; CaMos Research Group.

J Bone Miner Res. 2010 Sep;25(9):1948-57. doi: 10.1002/jbmr.95.

3.

Health-related quality of life in Canadian adolescents and young adults: normative data using the SF-36.

Hopman WM, Berger C, Joseph L, Towheed T, Prior JC, Anastassiades T, Poliquin S, Zhou W, Adachi JD, Hanley DA, Papadimitropoulos EA, Tenenhouse A; CaMos Research Group.

Can J Public Health. 2009 Nov-Dec;100(6):449-52.

4.

Vertebral fracture status and the World Health Organization risk factors for predicting osteoporotic fracture risk.

Chen P, Krege JH, Adachi JD, Prior JC, Tenenhouse A, Brown JP, Papadimitropoulos E, Kreiger N, Olszynski WP, Josse RG, Goltzman D; CaMOS Research Group.

J Bone Miner Res. 2009 Mar;24(3):495-502. doi: 10.1359/jbmr.081103.

5.

Association between change in BMD and fragility fracture in women and men.

Berger C, Langsetmo L, Joseph L, Hanley DA, Davison KS, Josse RG, Prior JC, Kreiger N, Tenenhouse A, Goltzman D; CaMos Research Group.

J Bone Miner Res. 2009 Feb;24(2):361-70. doi: 10.1359/jbmr.081004.

6.

The impact of incident fractures on health-related quality of life: 5 years of data from the Canadian Multicentre Osteoporosis Study.

Papaioannou A, Kennedy CC, Ioannidis G, Sawka A, Hopman WM, Pickard L, Brown JP, Josse RG, Kaiser S, Anastassiades T, Goltzman D, Papadimitropoulos M, Tenenhouse A, Prior JC, Olszynski WP, Adachi JD; CaMos Study Group.

Osteoporos Int. 2009 May;20(5):703-14. doi: 10.1007/s00198-008-0743-7. Epub 2008 Sep 19.

7.

Geographic variation of bone mineral density and selected risk factors for prediction of incident fracture among Canadians 50 and older.

Langsetmo L, Hanley DA, Kreiger N, Jamal SA, Prior J, Adachi JD, Davison KS, Kovacs C, Anastassiades T, Tenenhouse A, Goltzman D; CaMos Research Group.

Bone. 2008 Oct;43(4):672-8. doi: 10.1016/j.bone.2008.06.009. Epub 2008 Jul 1.

8.

Change in bone mineral density as a function of age in women and men and association with the use of antiresorptive agents.

Berger C, Langsetmo L, Joseph L, Hanley DA, Davison KS, Josse R, Kreiger N, Tenenhouse A, Goltzman D; Canadian Multicentre Osteoporosis Study Research Group.

CMAJ. 2008 Jun 17;178(13):1660-8. doi: 10.1503/cmaj.071416.

9.

The osteoporosis care gap in men with fragility fractures: the Canadian Multicentre Osteoporosis Study.

Papaioannou A, Kennedy CC, Ioannidis G, Gao Y, Sawka AM, Goltzman D, Tenenhouse A, Pickard L, Olszynski WP, Davison KS, Kaiser S, Josse RG, Kreiger N, Hanley DA, Prior JC, Brown JP, Anastassiades T, Adachi JD; CaMos Research Group.

Osteoporos Int. 2008 Apr;19(4):581-7. Epub 2007 Oct 9.

10.

Effectiveness of antiresorptive agents in the prevention of recurrent hip fractures.

Morin S, Rahme E, Behlouli H, Tenenhouse A, Goltzman D, Pilote L.

Osteoporos Int. 2007 Dec;18(12):1625-32. Epub 2007 Jul 19.

PMID:
17634854
11.

Changes to osteoporosis prevalence according to method of risk assessment.

Richards JB, Leslie WD, Joseph L, Siminoski K, Hanley DA, Adachi JD, Brown JP, Morin S, Papaioannou A, Josse RG, Prior JC, Davison KS, Tenenhouse A, Goltzman D; CaMos Study Group.

J Bone Miner Res. 2007 Feb;22(2):228-34.

12.

Bone strength: the whole is greater than the sum of its parts.

Davison KS, Siminoski K, Adachi JD, Hanley DA, Goltzman D, Hodsman AB, Josse R, Kaiser S, Olszynski WP, Papaioannou A, Ste-Marie LG, Kendler DL, Tenenhouse A, Brown JP.

Semin Arthritis Rheum. 2006 Aug;36(1):22-31. Epub 2006 Jul 3. Review.

PMID:
16887465
13.

The effects of antifracture therapies on the components of bone strength: assessment of fracture risk today and in the future.

Davison KS, Siminoski K, Adachi JD, Hanley DA, Goltzman D, Hodsman AB, Josse R, Kaiser S, Olszynski WP, Papaioannou A, Ste-Marie LG, Kendler DL, Tenenhouse A, Brown JP.

Semin Arthritis Rheum. 2006 Aug;36(1):10-21. Epub 2006 Jul 3. Review.

PMID:
16887464
14.

The effect of cyclooxygenase-2 inhibitors on bone mineral density: results from the Canadian Multicentre Osteoporosis Study.

Richards JB, Joseph L, Schwartzman K, Kreiger N, Tenenhouse A, Goltzman D; Canadian Multicentre Osteoporosis Study Group.

Osteoporos Int. 2006;17(9):1410-9. Epub 2006 Jun 22.

PMID:
16791706
15.

The use of multiple sites for the diagnosis of osteoporosis.

Kanis JA, Johnell O, Oden A, Johansson H, Eisman JA, Fujiwara S, Kroger H, Honkanen R, Melton LJ 3rd, O'Neill T, Reeve J, Silman A, Tenenhouse A.

Osteoporos Int. 2006;17(4):527-34. Epub 2006 Jan 10.

PMID:
16402164
16.

Determinants of health-related quality of life in women with vertebral fractures.

Papaioannou A, Kennedy CC, Ioannidis G, Brown JP, Pathak A, Hanley DA, Josse RG, Sebaldt RJ, Olszynski WP, Tenenhouse A, Murray TM, Petrie A, Goldsmith CH, Adachi JD.

Osteoporos Int. 2006;17(3):355-63. Epub 2005 Dec 9.

PMID:
16341623
17.

Are oral bisphosphonates effective in improving lumbar bone mineral density in breast cancer survivors with osteopenia or osteoporosis?

Sawka AM, Ioannidis G, Papaioannou A, Thabane L, Olszynski WP, Brown JP, Hanley DA, Murray TM, Josse RG, Sebaldt RJ, Petrie A, Tenenhouse A, Goldsmith CH, Boulos P, Kouroukis T, Adachi JD.

J Obstet Gynaecol Can. 2005 Aug;27(8):759-64.

PMID:
16287007
18.

Effectiveness of alendronate and etidronate in the treatment of osteoporosis in men: a prospective observational study.

Olszynski WP, Davison KS, Ioannidis G, Brown JP, Hanley DA, Josse RG, Murray TM, Papaioannou A, Sebaldt RJ, Tenenhouse AM, Petrie A, Goldsmith CH, Adachi JD.

Osteoporos Int. 2006 Feb;17(2):217-24. Epub 2005 Jul 5.

PMID:
15997420
19.

Predictive value of BMD for hip and other fractures.

Johnell O, Kanis JA, Oden A, Johansson H, De Laet C, Delmas P, Eisman JA, Fujiwara S, Kroger H, Mellstrom D, Meunier PJ, Melton LJ 3rd, O'Neill T, Pols H, Reeve J, Silman A, Tenenhouse A.

J Bone Miner Res. 2005 Jul;20(7):1185-94. Epub 2005 Mar 7. Erratum in: J Bone Miner Res. 2007 May;22(5):774.

20.

Body mass index as a predictor of fracture risk: a meta-analysis.

De Laet C, Kanis JA, Odén A, Johanson H, Johnell O, Delmas P, Eisman JA, Kroger H, Fujiwara S, Garnero P, McCloskey EV, Mellstrom D, Melton LJ 3rd, Meunier PJ, Pols HA, Reeve J, Silman A, Tenenhouse A.

Osteoporos Int. 2005 Nov;16(11):1330-8. Epub 2005 Jun 1. Review.

PMID:
15928804
21.

Univariate and bivariate variance component linkage analysis of a whole-genome scan for loci contributing to bone mineral density.

Devoto M, Spotila LD, Stabley DL, Wharton GN, Rydbeck H, Korkko J, Kosich R, Prockop D, Tenenhouse A, Sol-Church K.

Eur J Hum Genet. 2005 Jun;13(6):781-8.

22.

A family history of fracture and fracture risk: a meta-analysis.

Kanis JA, Johansson H, Oden A, Johnell O, De Laet C, Eisman JA, McCloskey EV, Mellstrom D, Melton LJ 3rd, Pols HA, Reeve J, Silman AJ, Tenenhouse A.

Bone. 2004 Nov;35(5):1029-37.

PMID:
15542027
23.

A meta-analysis of milk intake and fracture risk: low utility for case finding.

Kanis JA, Johansson H, Oden A, De Laet C, Johnell O, Eisman JA, Mc Closkey E, Mellstrom D, Pols H, Reeve J, Silman A, Tenenhouse A.

Osteoporos Int. 2005 Jul;16(7):799-804. Epub 2004 Oct 21.

PMID:
15502959
24.

Stability of normative data for the SF-36: results of a three-year prospective study in middle-aged Canadians.

Hopman WM, Berger C, Joseph L, Towheed T, vandenKerkhof E, Anastassiades T, Cranney A, Adachi JD, Loannidis G, Poliquin S, Brown JP, Murray TM, Hanley DA, Papadimitropoulos EA, Tenenhouse A; CaMos Research Group.

Can J Public Health. 2004 Sep-Oct;95(5):387-91.

PMID:
15490932
25.

Are there differences between men and women prescribed bisphosphonate therapy in canadian subspecialty osteoporosis practices?

Sawka AM, Adachi JD, Papaioannou A, Thabane L, Ioannidis G, Davison KS, Olszynski WP, Brown JP, Hanley DA, Murray TM, Josse RG, Sebaldt RJ, Petrie A, Tenenhouse A, Goldsmith CH.

J Rheumatol. 2004 Oct;31(10):1993-5.

PMID:
15468365
26.

Alcohol intake as a risk factor for fracture.

Kanis JA, Johansson H, Johnell O, Oden A, De Laet C, Eisman JA, Pols H, Tenenhouse A.

Osteoporos Int. 2005 Jul;16(7):737-42. Epub 2004 Sep 29.

PMID:
15455194
27.

A meta-analysis of previous fracture and subsequent fracture risk.

Kanis JA, Johnell O, De Laet C, Johansson H, Oden A, Delmas P, Eisman J, Fujiwara S, Garnero P, Kroger H, McCloskey EV, Mellstrom D, Melton LJ, Pols H, Reeve J, Silman A, Tenenhouse A.

Bone. 2004 Aug;35(2):375-82.

PMID:
15268886
28.

Smoking and fracture risk: a meta-analysis.

Kanis JA, Johnell O, Oden A, Johansson H, De Laet C, Eisman JA, Fujiwara S, Kroger H, McCloskey EV, Mellstrom D, Melton LJ, Pols H, Reeve J, Silman A, Tenenhouse A.

Osteoporos Int. 2005 Feb;16(2):155-62. Epub 2004 Jun 3.

PMID:
15175845
29.

A meta-analysis of prior corticosteroid use and fracture risk.

Kanis JA, Johansson H, Oden A, Johnell O, de Laet C, Melton III LJ, Tenenhouse A, Reeve J, Silman AJ, Pols HA, Eisman JA, McCloskey EV, Mellstrom D.

J Bone Miner Res. 2004 Jun;19(6):893-9. Epub 2004 Jan 27.

30.

Ability of peripheral DXA measurement to diagnose osteoporosis as assessed by central DXA measurement.

Picard D, Brown JP, Rosenthall L, Couturier M, Lévesque J, Dumont M, Ste-Marie LG, Tenenhouse A, Dodin S.

J Clin Densitom. 2004 Spring;7(1):111-8.

PMID:
14742895
31.

What predicts early fracture or bone loss on bisphosphonate therapy?

Sawka AM, Adachi JD, Ioannidis G, Olszynski WP, Brown JP, Hanley DA, Murray T, Josse R, Sebaldt RJ, Petrie A, Tenenhouse A, Papaioannou A, Goldsmith CH.

J Clin Densitom. 2003 Winter;6(4):315-22.

PMID:
14716043
32.

Association analysis of bone mineral density and single nucleotide polymorphisms in two candidate genes on chromosome 1p36.

Spotila LD, Rodriguez H, Koch M, Tenenhouse HS, Tenenhouse A, Li H, Devoto M.

Calcif Tissue Int. 2003 Aug;73(2):140-6.

PMID:
14565595
33.

Adherence to bisphosphonates and hormone replacement therapy in a tertiary care setting of patients in the CANDOO database.

Papaioannou A, Ioannidis G, Adachi JD, Sebaldt RJ, Ferko N, Puglia M, Brown J, Tenenhouse A, Olszynski WP, Boulos P, Hanley DA, Josse R, Murray TM, Petrie A, Goldsmith CH.

Osteoporos Int. 2003 Oct;14(10):808-13. Epub 2003 Sep 11.

PMID:
14523610
34.

The association between osteoporotic fractures and health-related quality of life as measured by the Health Utilities Index in the Canadian Multicentre Osteoporosis Study (CaMos).

Adachi JD, Ioannidis G, Pickard L, Berger C, Prior JC, Joseph L, Hanley DA, Olszynski WP, Murray TM, Anastassiades T, Hopman W, Brown JP, Kirkland S, Joyce C, Papaioannou A, Poliquin S, Tenenhouse A, Papadimitropoulos EA.

Osteoporos Int. 2003 Nov;14(11):895-904. Epub 2003 Aug 12.

PMID:
12920507
35.

Associations among disease conditions, bone mineral density, and prevalent vertebral deformities in men and women 50 years of age and older: cross-sectional results from the Canadian Multicentre Osteoporosis Study.

Hanley DA, Brown JP, Tenenhouse A, Olszynski WP, Ioannidis G, Berger C, Prior JC, Pickard L, Murray TM, Anastassiades T, Kirkland S, Joyce C, Joseph L, Papaioannou A, Jackson SA, Poliquin S, Adachi JD; Canadian Multicentre Osteoporosis Study Research Group.

J Bone Miner Res. 2003 Apr;18(4):784-90.

36.

A new approach to the development of assessment guidelines for osteoporosis.

Kanis JA, Black D, Cooper C, Dargent P, Dawson-Hughes B, De Laet C, Delmas P, Eisman J, Johnell O, Jonsson B, Melton L, Oden A, Papapoulos S, Pols H, Rizzoli R, Silman A, Tenenhouse A; International Osteoporosis Foundation; National Osteoporosis Foundation.

Osteoporos Int. 2002 Jul;13(7):527-36. No abstract available.

PMID:
12111012
37.

Multiple imputation to account for missing data in a survey: estimating the prevalence of osteoporosis.

Kmetic A, Joseph L, Berger C, Tenenhouse A.

Epidemiology. 2002 Jul;13(4):437-44.

PMID:
12094099
38.

Is there regional variation in the SF-36 scores of Canadian adults?

Hopman WM, Berger C, Joseph L, Towheed T, Anastassiades T, Tenenhouse A, Poliquin S, Brown JP, Murray TM, Adachi JD, Hanley DA, Papadimitropoulos EA; Canadian Multicentre Osteoporosis Study Research Group.

Can J Public Health. 2002 May-Jun;93(3):233-7.

PMID:
12050994
39.

The impact of incident vertebral and non-vertebral fractures on health related quality of life in postmenopausal women.

Adachi JD, Ioannidis G, Olszynski WP, Brown JP, Hanley DA, Sebaldt RJ, Petrie A, Tenenhouse A, Stephenson GF, Papaioannou A, Guyatt GH, Goldsmith CH.

BMC Musculoskelet Disord. 2002 Apr 22;3:11. Epub 2002 Apr 22.

40.

The influence of osteoporotic fractures on health-related quality of life in community-dwelling men and women across Canada.

Adachi JD, Loannidis G, Berger C, Joseph L, Papaioannou A, Pickard L, Papadimitropoulos EA, Hopman W, Poliquin S, Prior JC, Hanley DA, Olszynski WP, Anastassiades T, Brown JP, Murray T, Jackson SA, Tenenhouse A; Canadian Multicentre Osteoporosis Study (CaMos) Research Group.

Osteoporos Int. 2001;12(11):903-8.

PMID:
11804016
41.

Positive effect of etidronate therapy is maintained after drug is terminated in patients using corticosteroids.

Brown JP, Olszynski WP, Hodsman A, Bensen WG, Tenenhouse A, Anastassiades TP, Ste-Marie LG, Kendler DL, Hanley DA, Josse R, Hanly JG, Lentle B, Jovaisas A, Ioannidis G, Stephenson GF, Barton I, Pack S, Chines A, Dias R, Adachi JD.

J Clin Densitom. 2001 Winter;4(4):363-71.

PMID:
11748341
42.

Oral contraceptive use and bone mineral density in premenopausal women: cross-sectional, population-based data from the Canadian Multicentre Osteoporosis Study.

Prior JC, Kirkland SA, Joseph L, Kreiger N, Murray TM, Hanley DA, Adachi JD, Vigna YM, Berger C, Blondeau L, Jackson SA, Tenenhouse A.

CMAJ. 2001 Oct 16;165(8):1023-9.

43.

Variance component linkage analysis indicates a QTL for femoral neck bone mineral density on chromosome 1p36.

Devoto M, Specchia C, Li HH, Caminis J, Tenenhouse A, Rodriguez H, Spotila LD.

Hum Mol Genet. 2001 Oct 1;10(21):2447-52.

PMID:
11689491
44.

Estimation of the prevalence of low bone density in Canadian women and men using a population-specific DXA reference standard: the Canadian Multicentre Osteoporosis Study (CaMos).

Tenenhouse A, Joseph L, Kreiger N, Poliquin S, Murray TM, Blondeau L, Berger C, Hanley DA, Prior JC; CaMos Research Group.Canadian Multicentre Osteoporosis Study.

Osteoporos Int. 2000;11(10):897-904.

PMID:
11199195
45.
46.

Canadian normative data for the SF-36 health survey. Canadian Multicentre Osteoporosis Study Research Group.

Hopman WM, Towheed T, Anastassiades T, Tenenhouse A, Poliquin S, Berger C, Joseph L, Brown JP, Murray TM, Adachi JD, Hanley DA, Papadimitropoulos E.

CMAJ. 2000 Aug 8;163(3):265-71.

47.

Association of a polymorphism in the TNFR2 gene with low bone mineral density.

Spotila LD, Rodriguez H, Koch M, Adams K, Caminis J, Tenenhouse HS, Tenenhouse A.

J Bone Miner Res. 2000 Jul;15(7):1376-83.

48.

Management of corticosteroid-induced osteoporosis.

Adachi JD, Olszynski WP, Hanley DA, Hodsman AB, Kendler DL, Siminoski KG, Brown J, Cowden EA, Goltzman D, Ioannidis G, Josse RG, Ste-Marie LG, Tenenhouse AM, Davison KS, Blocka KL, Pollock AP, Sibley J.

Semin Arthritis Rheum. 2000 Feb;29(4):228-51. Review.

PMID:
10707991
49.

Biochemical markers of bone turnover. A look at laboratory tests that reflect bone status.

Rosen CJ, Tenenhouse A.

Postgrad Med. 1998 Oct;104(4):101-2, 107-10, 113-4. Review.

PMID:
9793558
50.

First-stage autosomal genome screen in extended pedigrees suggests genes predisposing to low bone mineral density on chromosomes 1p, 2p and 4q.

Devoto M, Shimoya K, Caminis J, Ott J, Tenenhouse A, Whyte MP, Sereda L, Hall S, Considine E, Williams CJ, Tromp G, Kuivaniemi H, Ala-Kokko L, Prockop DJ, Spotila LD.

Eur J Hum Genet. 1998 Mar-Apr;6(2):151-7.

Supplemental Content

Loading ...
Support Center